First Affiliated Hospital Of Fujian Medical University
People's Republic of China
- Country
- People's Republic of China
- Ownership
- Private
- Established
- 1937-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.fyyy.com
Clinical Trials
66
Active:3
Completed:9
Trial Phases
5 Phases
Early Phase 1:23
Phase 1:9
Phase 2:4
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (52 trials with phase data)• Click on a phase to view related trials
Early Phase 1
23 (44.2%)Not Applicable
15 (28.8%)Phase 1
9 (17.3%)Phase 2
4 (7.7%)Phase 4
1 (1.9%)PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension
Recruiting
- Conditions
- Pulmonary Hypertension
- First Posted Date
- 2025-08-20
- Last Posted Date
- 2025-08-20
- Target Recruit Count
- 1000
- Registration Number
- NCT07131241
- Locations
- 🇨🇳
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Prospective Clinical Trial of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Target Recruit Count
- 20
- Registration Number
- NCT07117760
- Locations
- 🇨🇳
Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation Study
Completed
- Conditions
- Renal Cell Carcinoma (RCC)
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Target Recruit Count
- 1437
- Registration Number
- NCT07117786
Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer
Not Applicable
Recruiting
- Conditions
- Prostate CA
- Interventions
- Drug: 68Ga-PSMA-CYCDrug: CYC
- First Posted Date
- 2025-07-09
- Last Posted Date
- 2025-07-09
- Target Recruit Count
- 40
- Registration Number
- NCT07056790
- Locations
- 🇨🇳
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73
- First Posted Date
- 2025-05-30
- Last Posted Date
- 2025-05-30
- Target Recruit Count
- 30
- Registration Number
- NCT06995976
- Locations
- 🇨🇳
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
News
No news found